Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients.

Turgeon, D K

Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients. [electronic resource] - Transplantation Jun 1994 - 1736-41 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0041-1337


Adult
Breath Tests
Cyclosporine
Cyclosporins--blood
Dose-Response Relationship, Drug
Erythromycin
Female
Humans
Immunosuppressive Agents--therapeutic use
Kidney Diseases--surgery
Kidney Transplantation--immunology
Male
Middle Aged
Patient Compliance
Predictive Value of Tests
Regression Analysis